What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Patient and physician perceptions on the symptomatic and economic burden of MPNs
Results of the Phase III DASISION trial and the future of CML treatment
Changing the way we treat multiple myeloma based on biological markers in 2016